Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

High Throughput Chemistry

Sygnature has a well-established High Throughput Chemistry lab which has efficiently produced small, diverse libraries for the European Lead Factory.

Over 5 years, Sygnature has produced over 40,000 drug-like molecules with novel three-dimensional character for the European Lead Factory. Our expertise in High Throughput Chemistry is also available to client projects and is especially useful in the hit-to-lead stage of the drug discovery process to rapidly expand hits and explore structure activity relationships.

  • Fully automated process for synthesis, purification and QC
    • Robotic reformatting at each stage
  • Each product traceable throughout the process by barcoded vials
    • Eliminates human / typographic errors
  • Mass-directed purification (ELS/UV option)
    • Single tube collection – compatible with wide range of structures/chromophores
  • Refined protocols for a range of robust reactions
    • Ambient to high temperature, wide range of solvents,
    • Homogeneous and heterogeneous methodologies

Progress in the early stages of Lead Identification and Lead Optimisation can be greatly accelerated by our teams and the use of this advanced technology.

Latest News

View All

Sygnature Discovery and Daewoong Pharma announce research…

New platform set to accelerate early-stage targeted…

Sygnature Discovery completes acquisition of SB Drug…

Sygnature Discovery partners the Oncology Development Programme…